CENTRAL GATESHEAD MEDICAL GROUP
PRINCE CONSORT ROAD, GATESHEAD
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 22 | 25 | 88.0% | |
| HF 4 | 2011 | 29 | 37 | 78.4% | |
| HF 4 | 2012 | 33 | 39 | 84.6% | |
| HF 4 | 2013 | 38 | 44 | 86.4% | |
| HF004 | 2014 | 36 | 40 | 90.0% | |
| HF004 | 2015 | 64 | 70 | 91.4% | |
| HF004 | 2016 | 70 | 77 | 90.9% | |
| HF004 | 2017 | 76 | 83 | 91.6% | |
| HF004 | 2018 | 81 | 89 | 91.0% | |
| HF004 | 2019 | 85 | 92 | 92.4% | |
| HF004 | 2020 | 78 | 83 | 94.0% | |
| HF006 | 2021 | 83 | 90 | 92.2% | |
| HF006 | 2022 | 84 | 88 | 95.5% | |
| HF006 | 2023 | 107 | 109 | 98.2% |
